Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

被引：16

作者：

Calcagno, A. ^{[1
]}

Baietto, L. ^{[2
]}

De Rosa, F. G. ^{[1
]}

Tettoni, M. C. ^{[1
]}

Libanore, V. ^{[1
]}

Bertucci, R. ^{[1
]}

D'Avolio, A. ^{[2
]}

Di Perri, G. ^{[1
]}

机构：

[1] Univ Turin, Dept Infect Dis, Turin, Italy

[2] Univ Turin, Pharmacokinet & Pharmacogenet Lab, Turin, Italy

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 01期

关键词：

antifungals; CSF penetration; darunavir; interactions; FLUID;

D O I：

10.1093/jac/dkq385

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：224 / 225

页数：2

共 7 条

[1] Omeprazole Significantly Reduces Posaconazole Serum Trough Level
Alffenaar, Jan-Willem C.
van Assen, Sander
van der Werf, Tjip S.
Kosterink, Jos G. W.
Uges, Donald R. A.
[J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (06) : 839 - 839
[2] An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients
D'Avolio, Antonio
Baietto, Lorena
Siccardi, Marco
Sciandra, Mauro
Simiele, Marco
Oddone, Valentina
Bonora, Stefano
Di Perri, Giovanni
[J]. THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 662 - 669
[3] Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
Reinwald, M.
Uharek, L.
Lampe, D.
Grobosch, T.
Thiel, E.
Schwartz, S.
[J]. BONE MARROW TRANSPLANTATION, 2009, 44 (04) : 269 - 270
[4] Posaconazole concentrations in the central nervous system
Rueping, Maria J. G. T.
Albermann, Nadine
Ebinger, Friedrich
Burckhardt, Irene
Beisel, Claudia
Mueller, Carsten
Vehreschild, Joerg J.
Kochanek, Matthias
Faetkenheuer, Gerd
Bangard, Christopher
Ullmann, Andrew J.
Herr, Wolfgang
Kolbe, Karin
Hallek, Michael
Cornely, Oliver A.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1468 - 1470
[5] In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes
Sun, QN
Fothergill, AW
McCarthy, DI
Rinaldi, MG
Graybill, JR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1581 - 1582
[6] Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection
Ullmann, AJ
Cornely, OA
Burchardt, A
Hachem, R
Kontoyiannis, DP
Töpelt, K
Courtney, R
Wexler, D
Krishna, G
Martinho, M
Corcoran, G
Raad, I
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 658 - 666
[7] Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1-Infected Individuals
Yilmaz, Aylin
Izadkhashti, Arash
Price, Richard W.
Mallon, Patrick W.
De Meulder, Marc
Timmerman, Philip
Gisslen, Magnus
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (04) : 457 - 461

← 1 →